We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Addus HomeCare (ADUS) Stock Undervalued Right Now?
Read MoreHide Full Article
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
Addus HomeCare (ADUS - Free Report) is a stock many investors are watching right now. ADUS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with P/E ratio of 19.56 right now. For comparison, its industry sports an average P/E of 20.68. Over the past 52 weeks, ADUS's Forward P/E has been as high as 28.16 and as low as 19.18, with a median of 24.52.
Investors should also note that ADUS holds a PEG ratio of 1.66. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. ADUS's industry has an average PEG of 2.98 right now. Within the past year, ADUS's PEG has been as high as 2.50 and as low as 1.64, with a median of 2.12.
Another valuation metric that we should highlight is ADUS's P/B ratio of 2.07. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. ADUS's current P/B looks attractive when compared to its industry's average P/B of 2.74. Over the past 12 months, ADUS's P/B has been as high as 2.95 and as low as 2.02, with a median of 2.58.
Finally, investors should note that ADUS has a P/CF ratio of 20.76. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 23.50. Over the past year, ADUS's P/CF has been as high as 30.54 and as low as 20.20, with a median of 26.69.
Investors could also keep in mind DaVita (DVA - Free Report) , an Medical - Outpatient and Home Healthcare stock with a Zacks Rank of # 2 (Buy) and Value grade of A.
DaVita is trading at a forward earnings multiple of 15.73 at the moment, with a PEG ratio of 1.87. This compares to its industry's average P/E of 20.68 and average PEG ratio of 2.98.
Over the last 12 months, DVA's P/E has been as high as 15.73, as low as 7.30, with a median of 11.03, and its PEG ratio has been as high as 1.87, as low as 0.80, with a median of 1.22.
Additionally, DaVita has a P/B ratio of 10.40 while its industry's price-to-book ratio sits at 2.74. For DVA, this valuation metric has been as high as 12.74, as low as 7.06, with a median of 9.12 over the past year.
These are just a handful of the figures considered in Addus HomeCare and DaVita's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that ADUS and DVA is an impressive value stock right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Addus HomeCare (ADUS) Stock Undervalued Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
Addus HomeCare (ADUS - Free Report) is a stock many investors are watching right now. ADUS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with P/E ratio of 19.56 right now. For comparison, its industry sports an average P/E of 20.68. Over the past 52 weeks, ADUS's Forward P/E has been as high as 28.16 and as low as 19.18, with a median of 24.52.
Investors should also note that ADUS holds a PEG ratio of 1.66. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. ADUS's industry has an average PEG of 2.98 right now. Within the past year, ADUS's PEG has been as high as 2.50 and as low as 1.64, with a median of 2.12.
Another valuation metric that we should highlight is ADUS's P/B ratio of 2.07. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. ADUS's current P/B looks attractive when compared to its industry's average P/B of 2.74. Over the past 12 months, ADUS's P/B has been as high as 2.95 and as low as 2.02, with a median of 2.58.
Finally, investors should note that ADUS has a P/CF ratio of 20.76. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 23.50. Over the past year, ADUS's P/CF has been as high as 30.54 and as low as 20.20, with a median of 26.69.
Investors could also keep in mind DaVita (DVA - Free Report) , an Medical - Outpatient and Home Healthcare stock with a Zacks Rank of # 2 (Buy) and Value grade of A.
DaVita is trading at a forward earnings multiple of 15.73 at the moment, with a PEG ratio of 1.87. This compares to its industry's average P/E of 20.68 and average PEG ratio of 2.98.
Over the last 12 months, DVA's P/E has been as high as 15.73, as low as 7.30, with a median of 11.03, and its PEG ratio has been as high as 1.87, as low as 0.80, with a median of 1.22.
Additionally, DaVita has a P/B ratio of 10.40 while its industry's price-to-book ratio sits at 2.74. For DVA, this valuation metric has been as high as 12.74, as low as 7.06, with a median of 9.12 over the past year.
These are just a handful of the figures considered in Addus HomeCare and DaVita's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that ADUS and DVA is an impressive value stock right now.